Cattle and Porcine Reproductive Diseases Market - Global Forecast To 2029
商品番号 : SMB-67692
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年10月 |
| ページ数 | 334 |
| 図表数 | 401 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global cattle & porcine/swine reproductive diseases market is projected to reach USD 975.8 million by 2029 from USD 758.2 million in 2024 at a CAGR of 5.2%.
世界の牛・豚の生殖器疾患市場は、5.2%のCAGRで2024年の7億5,820万米ドルから2029年までに9億7,580万米ドルに達すると予測されています。
Between January 2021 and August 2024, major players in this market adopted various strategies to expand their global presence and increase market share. These tactics include entering into strategic agreements, divestitures, expanding operations, and acquiring other companies. These efforts aim to enhance product portfolios, improve efficiency, and tap into new regional markets. The competitive landscape illustrates the industry’s focus on meeting the rising demand for reproductive disease treatments in cattle and pigs, which is crucial for supporting the global livestock sector.
“The Pharmaceutical segment is expected to grow at the second highest CAGR in the cattle & porcine/swine reproductive diseases market.”
By product type, the pharmaceuticals segment represents the second highest CAGR in the cattle & porcine/swine reproductive diseases market. This is mainly due to some crucial factors. Advancements in the manufacturing of vaccines, such as the development of more effective formulations and sustainable production practices, have a great influence on market growth. The demand for the above-mentioned pharmaceutical products has increased due to the growing incidence of reproductive diseases in farm animals. The development of diagnostic tools supplements the application of vaccines and antibiotics, enabling timely and efficient disease detection. These two innovations, along with other improvements in their efficacy, have strongly supported the top market position of the pharmaceuticals segment.
“Bovine Viral Diarrhea (BVD) segment witnessed the second-highest CAGR in the cattle & porcine/swine reproductive diseases market.”
BVD is expected to be the second fastest-growing segment in terms of CAGR in the cattle & porcine/swine reproductive diseases market during the forecast period. Several factors have contributed to this growth: first, BVD affects several million cattle worldwide, resulting in marked economic losses due to reduced milk production and poor meat quality. Further, the various symptoms and complications of the disease necessitate a fitting response on the part of farmers and veterinarians. Increased regulatory focus, besides active initiatives by the industry for control and eradication of BVD, also drives the market. As such efforts start turning more concentrated and fruitful, solutions and services directed at overcoming BVD further amplify the demand for the same, thereby fueling market growth.
“The Porcine segment of the cattle & porcine/swine reproductive diseases market accounted for the second largest market share.”
Based on animal type, the porcine segment accounted for the second largest market share in the cattle & porcine/swine reproductive diseases market because of high economic impact of diseases like Porcine Reproductive and Respiratory Syndrome (PRRS) on pig farms drives significant spending on management and prevention. Second, the global rise in pork consumption and intensive pig farming practices increase the risk of disease spread, highlighting the need for effective disease control. Lastly, ongoing research works in vaccine and treatment options for porcine diseases boost market growth by offering better solutions to manage and prevent outbreaks. As pork production continues to expand, the focus on controlling reproductive diseases in pigs remains a high priority, further driving market demand.
“Veterinary hospitals and clinics segment of the cattle & porcine/swine reproductive diseases market is expected to witness the second highest CAGR.”
By end user, veterinary hospitals & clinics are expected to record the second-highest CAGR in the cattle & porcine/swine reproductive diseases market during the forecast period. Several factors contribute to such significant growth. Veterinary hospitals & clinics provide a place of advanced diagnostics and treatments essential for such specialized care, especially in reproductive problems in livestock. Due to this realization, farmers view these facilities as a source of expert medical services, thus making them seek accurate disease detection and a definite treatment plan. Besides this, increasing awareness concerning regular visits to veterinary institutes has also made farmers rely more on such institutions for preventive as well as curative purposes. The quality and customized services offered by veterinary clinics and hospitals contribute considerably to their popularity in the market.
“North America is expected to have the second highest CAGR in the cattle & porcine/swine reproductive diseases market, in the forecast period.”
In the North America region, the cattle & porcine/swine reproductive diseases market has grown significantly. The region’s extensive cattle and pig farms drive a significant demand for reproductive health products and services. This demand is supported by well-established veterinary research institutions that foster innovation and advancements in disease management. Furthermore, strong government support and funding for animal health initiatives in countries such as the US and Canada enhance the market’s robustness. The emphasis on boosting livestock productivity and upholding high standards of animal welfare also strengthens the region’s position in the global market.
A breakdown of the primary participants (supply side) for the cattle & porcine/swine reproductive diseases market referred to for this report is provided below:
- By Company Type: Tier 1–45%, Tier 2–20%, and Tier 3–35%
- By Designation: C-level–35%, Director Level–25%, and Others–40%
- By Region: North America–40%, Europe–20%, Asia Pacific–25%, Latin America-10%, and Middle East & Africa-5%
A breakdown of the primary participants (demand side) for the cattle & porcine/swine reproductive diseases market refer to for the report is provided below:
- By End User Type: Cattle and Porcine Farms-55%, Veterinary Hospitals and Clinics-30%, and Veterinary Reference Laboratory-15%
- By Designation: Veterinarians-45%, Farm Owners-40%, and Laboratory Technicians-15%
- By Region: North America–34%, Europe–27%, Asia Pacific–23%, Latin America-9%, and Middle East & Africa-7%
Key Market Players:
The prominent players in the cattle & porcine/swine reproductive diseases market include Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmBH (Germany), Virbac (France), Elanco Animal Health Incorporated (US), Vetoquinol S.A. (France), Ceva Santé Animale (France), Idexx Laboratories (US), Thermo Fisher Scientific Inc. (US), Biochek Smart Veterinary Diagnostics (Netherlands), Ring Biotechnology Co Ltd. (China), Sequent Scientific Limited (India), Hipra (Spain), Qiagen N.V. (Germany), Innovative Diagnostics (France), Colorado Serum Company (US), Indian Immunologicals Ltd (US), Refit Animal Care (India), Calier (US), Megacor Diagnostik GmBH (Austria), Vetanco (Brazil), Biogenesis Bago (Argentina), Advacare Pharma (US), Bio-X Diagnostics S.A. (Belgium), Pax Healthcare (India).
Research Coverage:
The market analysis examines the cattle & porcine/swine reproductive diseases market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product type, disease type, animal type, end user type and geography. The study also includes a detailed competitive analysis of the market’s top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the cattle & porcine/swine reproductive diseases market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.
This report provides insights into the following pointers:
Analysis of key Drivers: Drivers (Rising demand for animal-derived food products, Increasing prevalence of reproductive health issues, Growing number of veterinary practitioner in developed markets, Increasing per capita income of farmers in developing countries), Restrains (Lack of awareness and knowledge among small-scale farmers), Opportunities (Advancements in veterinary healthcare, Untapped emerging markets), Challenges (Stringent regulatory guidelines for livestock industry) influencing the growth of the cattle & porcine/swine reproductive diseases market.
- Market Penetration: Comprehensive information on the product portfolios of the leading companies in the cattle & porcine/swine reproductive diseases market. The report breaks down the market by product type, disease type, animal type, end user type and region.
- Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the cattle & porcine/swine reproductive diseases market.
- Market Development: Comprehensive data on attractive rising markets broken down by product type, disease type, animal type, end user type and region.
- Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the cattle & porcine/swine reproductive diseases market.
- Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main udder health products manufacturers.
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 30
1.2.2 MARKETS COVERED 31
1.2.3 YEARS CONSIDERED 32
1.2.4 CURRENCY CONSIDERED 32
1.3 MARKET STAKEHOLDERS 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH APPROACH 34
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
2.1.2.1 Primary sources 37
2.1.2.2 Key data from primary sources 38
2.1.2.3 Key industry insights 39
2.2 MARKET SIZE ESTIMATION 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 46
2.4 MARKET SHARE ESTIMATION 47
2.4.1 STUDY ASSUMPTIONS 47
2.5 RISK ASSESSMENT 48
2.6 RESEARCH LIMITATIONS 48
2.6.1 METHODOLOGY-RELATED LIMITATIONS 48
2.6.2 SCOPE-RELATED LIMITATIONS 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 55
4.1 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET OVERVIEW 55
4.2 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT AND COUNTRY (2023) 56
4.3 REGIONAL MIX: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET 57
4.4 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET:
GEOGRAPHICAL GROWTH OPPORTUNITIES 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
5.2.1 DRIVERS 59
5.2.1.1 Growing demand for animal−derived food products 59
5.2.1.2 Increasing prevalence of reproductive health issues 61
5.2.1.3 Rising number of veterinary practitioners in developed markets 62
5.2.1.4 Increasing per capita income of farmers in emerging markets 63
5.2.2 RESTRAINTS 64
5.2.2.1 Limited awareness & education among small-scale farmers 64
5.2.3 OPPORTUNITIES 64
5.2.3.1 Advancements in veterinary healthcare 64
5.2.3.2 High growth potential of emerging economies 65
5.2.4 CHALLENGES 65
5.2.4.1 Stringent regulatory guidelines for livestock industry 65
5.3 INDUSTRY TRENDS 66
5.3.1 INCREASING ADOPTION OF VACCINATION PROGRAMS 66
5.3.2 EMPHASIS ON SUSTAINABLE PRACTICES 66
5.4 TECHNOLOGY ANALYSIS 67
5.4.1 KEY TECHNOLOGIES 67
5.4.1.1 Vaccination technologies 67
5.4.1.2 Diagnostic tools 67
5.4.2 COMPLEMENTARY TECHNOLOGIES 67
5.4.2.1 Genomic selection & breeding 68
5.4.2.2 Precision livestock farming 68
5.4.3 ADJACENT TECHNOLOGIES 69
5.4.3.1 Nutritional supplements & additives 69
5.4.3.2 Integration of livestock management software 69
5.5 PORTER’S FIVE FORCES ANALYSIS 70
5.5.1 THREAT OF NEW ENTRANTS 70
5.5.2 BARGAINING POWER OF SUPPLIERS 71
5.5.3 BARGAINING POWER OF BUYERS 71
5.5.4 THREAT OF SUBSTITUTES 71
5.5.5 COMPETITIVE RIVALRY 72
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA 74
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
5.6.2 BUYING CRITERIA 74
5.7 REGULATORY LANDSCAPE 75
5.7.1 REGULATORY ANALYSIS 75
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
5.8 PATENT ANALYSIS 80
5.8.1 PATENT PUBLICATION TRENDS FOR CATTLE & PORCINE
REPRODUCTIVE DISEASES MARKET 80
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 81
5.9 TRADE ANALYSIS 84
5.9.1 TRADE ANALYSIS FOR CATTLE & PORCINE REPRODUCTIVE PRODUCTS 84
5.10 PRICING ANALYSIS 85
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE 85
5.10.2 AVERAGE SELLING PRICE TREND OF CATTLE & PORCINE REPRODUCTIVE HEALTH PRODUCTS, BY REGION 86
5.11 REIMBURSEMENT ANALYSIS 87
5.12 KEY CONFERENCES AND EVENTS 88
5.13 UNMET NEEDS/END-USER EXPECTATIONS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET 89
5.14 IMPACT OF GEN AI ON CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET 90
5.15 ECOSYSTEM ANALYSIS 91
5.16 CASE STUDY ANALYSIS 93
5.16.1 INNOVATION IN BOVINE REPRODUCTIVE DISEASE VACCINATION 93
5.16.2 TECH-DRIVEN SOLUTIONS FOR LIVESTOCK REPRODUCTIVE HEALTH 93
5.16.3 INTEGRATED HEALTH SOLUTIONS FOR CATTLE REPRODUCTIVE HEALTH 94
5.17 SUPPLY CHAIN ANALYSIS 95
5.18 VALUE CHAIN ANALYSIS 96
5.19 ADJACENT MARKETS FOR CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET 97
5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESSES 98
5.21 INVESTMENT & FUNDING SCENARIO 98
6 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT 99
6.1 INTRODUCTION 100
6.2 DIAGNOSTICS 100
6.2.1 ELISA TEST KITS 103
6.2.1.1 Advancements in biotechnology to drive market 103
6.2.2 PCR TEST KITS 105
6.2.2.1 Increasing adoption of on-farm PCR testing solutions to fuel uptake 105
6.2.3 RAPID ANTIGEN TEST KITS 107
6.2.3.1 Growing demand for reliable solutions with quick turnaround
time to drive market 107
6.2.4 OTHER DIAGNOSTIC PRODUCTS 109
6.3 PHARMACEUTICALS 111
6.3.1 VACCINES 113
6.3.1.1 Enhancements in vaccine technology & formulation to drive market 113
6.3.2 ANTIBIOTICS 115
6.3.2.1 Convenient purchase options and long-term benefits to
boost demand 115
6.3.3 HORMONAL THERAPY 117
6.3.3.1 Ability to mimic natural hormones to boost demand 117
6.3.4 OTHER PHARMACEUTICAL PRODUCTS 119
6.4 SUPPLEMENTS 121
6.4.1 VITAMINS & MINERALS 123
6.4.1.1 Rising focus on nutrition and reproductive health to
support market growth 123
6.4.2 OTHER SUPPLEMENTS 125
7 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE 127
7.1 INTRODUCTION 128
7.2 LEPTOSPIROSIS 129
7.2.1 RISING CASES DUE TO CLIMATE CHANGE TO DRIVE MARKET 129
7.3 BRUCELLOSIS 131
7.3.1 IMPACT ON LIVESTOCK PRODUCTIVITY DUE TO CONTAGIOUS NATURE TO SUPPORT MARKET GROWTH 131
7.4 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) 133
7.4.1 INCREASING PORK CONSUMPTION TO PROPEL MARKET 133
7.5 BOVINE VIRAL DIARRHEA (BVD) 135
7.5.1 HIGH MORBIDITY RATE TO DRIVE MARKET 135
7.6 VIBRIOSIS 137
7.6.1 GROWING DEMAND FOR HIGH-YIELDING LIVESTOCK TO
SUPPORT MARKET GROWTH 137
7.7 OTHER CATTLE & PORCINE DISEASES 139
8 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE 141
8.1 INTRODUCTION 142
8.2 CATTLE 142
8.2.1 DAIRY CATTLE 145
8.2.1.1 Increasing demand for milk & dairy products to boost demand 145
8.2.2 BEEF CATTLE 147
8.2.2.1 Increasing demand for beef to drive market 147
8.3 PORCINE 149
9 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER 151
9.1 INTRODUCTION 152
9.2 CATTLE & PORCINE FARMS 152
9.2.1 GROWING DEMAND FOR MEAT & DAIRY PRODUCTS TO DRIVE MARKET 152
9.3 VETERINARY HOSPITALS & CLINICS 154
9.3.1 INCREASING VETERINARY HEALTHCARE INVESTMENTS IN EMERGING MARKETS TO BOOST DEMAND 154
9.4 VETERINARY REFERENCE LABORATORIES 156
9.4.1 INCREASING TECHNOLOGICAL ADVANCEMENTS IN VETERINARY DIAGNOSTICS TO SUPPORT MARKET GROWTH 156
10 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION 158
10.1 INTRODUCTION 159
10.2 NORTH AMERICA 160
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 160
10.2.2 US 164
10.2.2.1 Large-scale livestock operations and advanced veterinary
practices to drive market 164
10.2.3 CANADA 167
10.2.3.1 Rising concerns about food safety & quality to fuel market 167
10.3 EUROPE 171
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 171
10.3.2 GERMANY 176
10.3.2.1 Adoption of advanced technologies for milk & dairy products
to drive market 176
10.3.3 UK 180
10.3.3.1 Favorable government support for animal healthcare
to boost demand 180
10.3.4 FRANCE 183
10.3.4.1 Growth in veterinary & healthcare industries to drive market 183
10.3.5 ITALY 186
10.3.5.1 Growing focus on swine & dairy farming to fuel uptake 186
10.3.6 SWITZERLAND 190
10.3.6.1 Technologically advanced agriculture sector to fuel market 190
10.3.7 SPAIN 193
10.3.7.1 High exports of meat & milk to contribute to market growth 193
10.3.8 REST OF EUROPE 197
10.4 ASIA PACIFIC 200
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 200
10.4.2 JAPAN 204
10.4.2.1 Rising focus on dairy industry to drive market 204
10.4.3 CHINA 207
10.4.3.1 Rising prevalence of infectious diseases in livestock to propel market 207
10.4.4 INDIA 211
10.4.4.1 Expanding cattle population to boost demand 211
10.4.5 AUSTRALIA 215
10.4.5.1 Emphasis on sustainable & systematic farming practices to
support market growth 215
10.4.6 SOUTH KOREA 218
10.4.6.1 Rise in pork & beef consumption to drive market 218
10.4.7 REST OF ASIA PACIFIC 221
10.5 LATIN AMERICA 224
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 225
10.5.2 BRAZIL 228
10.5.2.1 Growing demand for veterinary services to fuel uptake 228
10.5.3 MEXICO 231
10.5.3.1 Improvements in animal welfare to support market growth 231
10.5.4 REST OF LATIN AMERICA 235
10.6 MIDDLE EAST & AFRICA 238
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 238
10.6.2 GCC COUNTRIES 242
10.6.2.1 Growing demand for dairy to fuel market 242
10.6.3 REST OF MIDDLE EAST & AFRICA 245
11 COMPETITIVE LANDSCAPE 248
11.1 OVERVIEW 248
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 248
11.3 REVENUE ANALYSIS 250
11.4 MARKET SHARE ANALYSIS 251
11.4.1 RANKING OF KEY MARKET PLAYERS 253
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 253
11.5.1 STARS 253
11.5.2 EMERGING LEADERS 253
11.5.3 PERVASIVE PLAYERS 254
11.5.4 PARTICIPANTS 254
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 255
11.5.5.1 Company footprint 255
11.5.5.2 Product footprint 256
11.5.5.3 Disease type footprint 257
11.5.5.4 Animal type footprint 258
11.5.5.5 End-user footprint 259
11.5.5.6 Region footprint 260
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 261
11.6.1 PROGRESSIVE COMPANIES 261
11.6.2 DYNAMIC COMPANIES 261
11.6.3 STARTING BLOCKS 261
11.6.4 RESPONSIVE COMPANIES 261
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 263
11.7 COMPANY VALUATION & FINANCIAL METRICS 265
11.7.1 COMPANY VALUATION 265
11.7.2 FINANCIAL METRICS 265
11.8 BRAND/PRODUCT COMPARISON 266
11.9 R&D EXPENDITURE OF KEY PLAYERS 266
11.10 COMPETITIVE SCENARIO 267
11.10.1 PRODUCT APPROVALS/LAUNCHES 267
11.10.2 DEALS 267
11.10.3 EXPANSIONS 268
11.10.4 OTHER DEVELOPMENTS 269
12 COMPANY PROFILES 270
12.1 KEY PLAYERS 270
12.1.1 ZOETIS INC. 270
12.1.1.1 Business overview 270
12.1.1.2 Products offered 271
12.1.1.3 Recent developments 272
12.1.1.3.1 Deals 272
12.1.1.3.2 Expansions 273
12.1.1.3.3 Other developments 273
12.1.1.4 MnM view 274
12.1.1.4.1 Key strengths 274
12.1.1.4.2 Strategic choices 274
12.1.1.4.3 Weaknesses & competitive threats 274
12.1.2 MERCK & CO., INC. 275
12.1.2.1 Business overview 275
12.1.2.2 Products offered 277
12.1.2.3 Recent developments 277
12.1.2.3.1 Deals 277
12.1.2.3.2 Other developments 278
12.1.2.4 MnM view 278
12.1.2.4.1 Key strengths 278
12.1.2.4.2 Strategic choices 278
12.1.2.4.3 Weaknesses & competitive threats 278
12.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 279
12.1.3.1 Business overview 279
12.1.3.2 Products offered 280
12.1.3.3 Recent developments 281
12.1.3.3.1 Product launches 281
12.1.3.4 MnM view 281
12.1.3.4.1 Key strengths 281
12.1.3.4.2 Strategic choices 282
12.1.3.4.3 Weaknesses & competitive threats 282
12.1.4 VIRBAC 283
12.1.4.1 Business overview 283
12.1.4.2 Products offered 284
12.1.4.3 Recent developments 285
12.1.4.3.1 Deals 285
12.1.4.3.2 Expansions 285
12.1.4.4 MnM view 286
12.1.4.4.1 Key strengths 286
12.1.4.4.2 Strategic choices 286
12.1.4.4.3 Weaknesses & competitive threats 286
12.1.5 ELANCO ANIMAL HEALTH INCORPORATED 287
12.1.5.1 Business overview 287
12.1.5.2 Products offered 288
12.1.5.3 Recent developments 289
12.1.5.3.1 Deals 289
12.1.5.3.2 Expansions 289
12.1.5.4 MnM view 289
12.1.5.4.1 Key strengths 289
12.1.5.4.2 Strategic choices 290
12.1.5.4.3 Weaknesses & competitive threats 290
12.1.6 VETOQUINOL S.A. 291
12.1.6.1 Business overview 291
12.1.6.2 Products offered 293
12.1.7 CEVA SANTÉ ANIMALE 294
12.1.7.1 Business overview 294
12.1.7.2 Products offered 294
12.1.7.3 Recent developments 295
12.1.7.3.1 Deals 295
12.1.8 IDEXX LABORATORIES, INC. 296
12.1.8.1 Business overview 296
12.1.8.2 Products offered 297
12.1.8.3 Recent developments 298
12.1.8.3.1 Other developments 298
12.1.9 THERMO FISHER SCIENTIFIC INC. 299
12.1.9.1 Business overview 299
12.1.9.2 Products offered 301
12.1.10 BIOCHEK SMART VETERINARY DIAGNOSTICS 302
12.1.10.1 Business overview 302
12.1.10.2 Products offered 302
12.1.10.3 Recent developments 303
12.1.10.3.1 Expansions 303
12.1.11 RING BIOTECHNOLOGY CO LTD. 304
12.1.11.1 Business overview 304
12.1.11.2 Products offered 304
12.1.11.3 Recent developments 305
12.1.11.3.1 Product launches & approvals 305
12.1.12 SEQUENT SCIENTIFIC LIMITED 306
12.1.12.1 Business overview 306
12.1.12.2 Products offered 307
12.1.13 HIPRA 308
12.1.13.1 Business overview 308
12.1.13.2 Products offered 308
12.1.14 QIAGEN N.V. 309
12.1.14.1 Business overview 309
12.1.14.2 Products offered 310
12.1.15 INNOVATIVE DIAGNOSTICS 311
12.1.15.1 Business overview 311
12.1.15.2 Products offered 311
12.1.15.3 Recent developments 312
12.1.15.3.1 Other developments 312
12.2 OTHER PLAYERS 313
12.2.1 COLORADO SERUM COMPANY 313
12.2.2 INDIAN IMMUNOLOGICALS LTD. 314
12.2.3 REFIT ANIMAL CARE 315
12.2.4 CALIER 316
12.2.5 MEGACOR DIAGNOSTIK GMBH 317
12.2.6 VETANCO 318
12.2.7 BIOGENESIS BAGO 319
12.2.8 ADVACARE PHARMA 320
12.2.9 BIO-X DIAGNOSTICS S.A. 321
12.2.10 PAX HEALTHCARE 322
13 APPENDIX 323
13.1 DISCUSSION GUIDE 323
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 330
13.3 CUSTOMIZATION OPTIONS 332
13.4 RELATED REPORTS 332
13.5 AUTHOR DETAILS 333
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 32
TABLE 2 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET:
STUDY ASSUMPTION ANALYSIS 47
TABLE 3 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET:
RISK ASSESSMENT ANALYSIS 48
TABLE 4 PAST & PROJECTED TRENDS IN CONSUMPTION OF MEAT & MILK IN DEVELOPED AND EMERGING MARKETS (2002−2030) 61
TABLE 5 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET:
PORTER’S FIVE FORCES ANALYSIS 70
TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 74
TABLE 7 KEY BUYING CRITERIA FOR TOP THREE END USERS 75
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 79
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 79
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 12 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: LIST OF MAJOR PATENTS 83
TABLE 13 IMPORT AND EXPORT DATA FOR PRODUCTS RELATED TO CATTLE, PORCINE, REPRODUCTIVE, BY COUNTRY 84
TABLE 14 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE 85
TABLE 15 AVERAGE SELLING PRICE OF CATTLE & PORCINE REPRODUCTIVE HEALTH PRODUCTS, BY REGION 86
TABLE 16 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2024−2025) 88
TABLE 17 UNMET NEEDS/END-USER EXPECTATIONS IN CATTLE & PORCINE
REPRODUCTIVE DISEASES MARKET 89
TABLE 18 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: IMPACT OF GEN AI 90
TABLE 19 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ROLE IN ECOSYSTEM 92
TABLE 20 CASE STUDY ONE: INNOVATION IN BOVINE REPRODUCTIVE DISEASE
VACCINATION BY ZOETIS, INC. 93
TABLE 21 CASE STUDY TWO: TECH-DRIVEN SOLUTIONS FOR LIVESTOCK REPRODUCTIVE HEALTH BY CEVA SANTÉ ANIMALE (FRANCE) 93
TABLE 22 CASE STUDY THREE: INTEGRATED HEALTH SOLUTIONS FOR CATTLE REPRODUCTIVE HEALTH BY ELANCO ANIMAL HEALTH 94
TABLE 23 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 100
TABLE 24 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS,
BY TYPE, 2022–2029 (USD MILLION) 101
TABLE 25 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS,
BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 26 ELISA TEST KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 27 PCR TEST KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 28 RAPID ANTIGEN TEST KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 29 OTHER DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 110
TABLE 30 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 111
TABLE 31 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 32 VACCINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 33 ANTIBIOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 34 HORMONAL THERAPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 35 OTHER PHARMACEUTICAL PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 120
TABLE 36 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS,
BY TYPE, 2022–2029 (USD MILLION) 121
TABLE 37 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 38 VITAMINS & MINERALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 39 OTHER SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 40 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 128
TABLE 41 LEPTOSPIROSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 42 BRUCELLOSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 43 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 44 BOVINE VIRAL DIARRHEA (BVD) MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 136
TABLE 45 VIBRIOSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 46 OTHER CATTLE & PORCINE DISEASES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 140
TABLE 47 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 142
TABLE 48 CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 49 CATTLE REPRODUCTIVE DISEASES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 144
TABLE 50 DAIRY CATTLE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 51 BEEF CATTLE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 52 PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 150
TABLE 53 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER,
2022–2029 (USD MILLION) 152
TABLE 54 CATTLE & PORCINE FARMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 55 VETERINARY HOSPITALS & CLINICS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 155
TABLE 56 VETERINARY REFERENCE LABORATORIES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 157
TABLE 57 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION,
2022–2029 (USD MILLION) 160
TABLE 58 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 59 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 161
TABLE 60 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 161
TABLE 61 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 162
TABLE 62 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 162
TABLE 63 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 162
TABLE 64 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 163
TABLE 65 NORTH AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 163
TABLE 66 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 163
TABLE 67 US: KEY MACROINDICATORS 164
TABLE 68 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 165
TABLE 69 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS,
BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 70 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 71 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 72 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 166
TABLE 73 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 166
TABLE 74 US: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 167
TABLE 75 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER,
2022–2029 (USD MILLION) 167
TABLE 76 CANADA: KEY MACROINDICATORS 168
TABLE 77 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 168
TABLE 78 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 79 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 80 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 81 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 170
TABLE 82 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 170
TABLE 83 CANADA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 170
TABLE 84 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 171
TABLE 85 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 86 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 173
TABLE 87 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 88 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 89 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 90 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 175
TABLE 91 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 175
TABLE 92 EUROPE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 175
TABLE 93 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 176
TABLE 94 GERMANY: KEY MACROINDICATORS 177
TABLE 95 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 177
TABLE 96 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 177
TABLE 97 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 98 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 99 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 178
TABLE 100 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 179
TABLE 101 GERMANY: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 179
TABLE 102 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 179
TABLE 103 UK: KEY MACROINDICATORS 180
TABLE 104 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 180
TABLE 105 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS,
BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 106 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 107 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 108 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 182
TABLE 109 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 182
TABLE 110 UK: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 182
TABLE 111 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER,
2022–2029 (USD MILLION) 183
TABLE 112 FRANCE: KEY MACROINDICATORS 183
TABLE 113 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 184
TABLE 114 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 115 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 116 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 117 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 185
TABLE 118 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 185
TABLE 119 FRANCE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 186
TABLE 120 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 186
TABLE 121 ITALY: KEY MACROINDICATORS 187
TABLE 122 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 187
TABLE 123 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 124 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 125 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 126 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, DISEASE TYPE, 2022–2029 (USD MILLION) 188
TABLE 127 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 189
TABLE 128 ITALY: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 189
TABLE 129 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 189
TABLE 130 SWITZERLAND: KEY MACROINDICATORS 190
TABLE 131 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 191
TABLE 132 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 133 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 134 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 135 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 192
TABLE 136 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 192
TABLE 137 SWITZERLAND: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 193
TABLE 138 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 193
TABLE 139 SPAIN: KEY MACROINDICATORS 194
TABLE 140 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 194
TABLE 141 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 142 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 143 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 144 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 195
TABLE 145 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 196
TABLE 146 SPAIN: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 196
TABLE 147 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 196
TABLE 148 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 197
TABLE 149 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 150 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 151 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 152 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 199
TABLE 153 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 199
TABLE 154 REST OF EUROPE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 199
TABLE 155 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 200
TABLE 156 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 157 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 201
TABLE 158 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 159 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 160 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 161 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 203
TABLE 162 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 203
TABLE 163 ASIA PACIFIC: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 203
TABLE 164 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 204
TABLE 165 JAPAN: KEY MACROINDICATORS 204
TABLE 166 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 205
TABLE 167 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 168 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 169 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 170 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 206
TABLE 171 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 206
TABLE 172 JAPAN: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 207
TABLE 173 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 207
TABLE 174 CHINA: KEY MACROINDICATORS 208
TABLE 175 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 208
TABLE 176 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 177 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 178 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 179 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 210
TABLE 180 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 210
TABLE 181 CHINA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 210
TABLE 182 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 211
TABLE 183 INDIA: KEY MACROINDICATORS 212
TABLE 184 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 212
TABLE 185 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 186 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 187 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 188 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 213
TABLE 189 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 214
TABLE 190 INDIA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 214
TABLE 191 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 214
TABLE 192 AUSTRALIA: KEY MACROINDICATORS 215
TABLE 193 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 215
TABLE 194 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 195 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 196 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 197 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 217
TABLE 198 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 217
TABLE 199 AUSTRALIA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 217
TABLE 200 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 218
TABLE 201 SOUTH KOREA: KEY MACROINDICATORS 218
TABLE 202 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 219
TABLE 203 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 204 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 205 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 206 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 220
TABLE 207 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 220
TABLE 208 SOUTH KOREA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 221
TABLE 209 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 221
TABLE 210 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 222
TABLE 211 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 212 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 213 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 214 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 223
TABLE 215 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 223
TABLE 216 REST OF ASIA PACIFIC: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 217 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 224
TABLE 218 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 219 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 225
TABLE 220 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 221 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 222 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 223 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 227
TABLE 224 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 227
TABLE 225 LATIN AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 227
TABLE 226 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 228
TABLE 227 BRAZIL: KEY MACROINDICATORS 228
TABLE 228 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 229
TABLE 229 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 230 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 231 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 232 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 230
TABLE 233 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 230
TABLE 234 BRAZIL: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 231
TABLE 235 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 231
TABLE 236 MEXICO: KEY MACROINDICATORS 232
TABLE 237 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 232
TABLE 238 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 232
TABLE 239 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 240 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 241 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 233
TABLE 242 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 234
TABLE 243 MEXICO: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 234
TABLE 244 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 234
TABLE 245 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 235
TABLE 246 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 247 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 248 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 249 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 237
TABLE 250 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 237
TABLE 251 REST OF LATIN AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 252 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 238
TABLE 253 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION) 239
TABLE 254 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 239
TABLE 255 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 256 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 257 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 258 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 240
TABLE 259 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 241
TABLE 260 MIDDLE EAST & AFRICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 261 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 241
TABLE 262 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 242
TABLE 263 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 264 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 265 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 266 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY DISEASE TYPE, 2022–2029 (USD MILLION) 243
TABLE 267 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY ANIMAL TYPE, 2022–2029 (USD MILLION) 244
TABLE 268 GCC COUNTRIES: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE,
2022–2029 (USD MILLION) 244
TABLE 269 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET,
BY END USER, 2022–2029 (USD MILLION) 244
TABLE 270 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 245
TABLE 271 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 272 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 273 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 274 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 246
TABLE 275 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 247
TABLE 276 REST OF MIDDLE EAST & AFRICA: CATTLE REPRODUCTIVE DISEASES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 277 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION) 247
TABLE 278 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET 248
TABLE 279 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DEGREE OF COMPETITION 251
TABLE 280 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PRODUCT FOOTPRINT 256
TABLE 281 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DISEASE TYPE FOOTPRINT 257
TABLE 282 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ANIMAL TYPE FOOTPRINT 258
TABLE 283 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: END-USER FOOTPRINT 259
TABLE 284 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: REGION FOOTPRINT 260
TABLE 285 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DETAILED LIST OF
KEY STARTUP/SME PLAYERS 263
TABLE 286 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 264
TABLE 287 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET:
PRODUCT LAUNCHES, JANUARY 2021−AUGUST 2024 267
TABLE 288 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET:
DEALS, JANUARY 2021−AUGUST 2024 267
TABLE 289 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: EXPANSIONS,
JANUARY 2021−AUGUST 2024 268
TABLE 290 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: OTHER DEVELOPMENTS, JANUARY 2021−AUGUST 2024 269
TABLE 291 ZOETIS INC.: COMPANY OVERVIEW 270
TABLE 292 ZOETIS INC: PRODUCTS OFFERED 271
TABLE 293 ZOETIS INC.: DEALS, JANUARY 2021–AUGUST 2024 272
TABLE 294 ZOETIS INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024 273
TABLE 295 ZOETIS INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024 273
TABLE 296 MERCK & CO., INC.: COMPANY OVERVIEW 275
TABLE 297 MERCK & CO., INC.: PRODUCTS OFFERED 277
TABLE 298 MERCK & CO., INC.: DEALS, JANUARY 2021–AUGUST 2024 277
TABLE 299 MERCK & CO., INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024 278
TABLE 300 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW 279
TABLE 301 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED 280
TABLE 302 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024 281
TABLE 303 VIRBAC: COMPANY OVERVIEW 283
TABLE 304 VIRBAC: PRODUCTS OFFERED 284
TABLE 305 VIRBAC: DEALS, JANUARY 2021–AUGUST 2024 285
TABLE 306 VIRBAC: EXPANSIONS, JANUARY 2021–AUGUST 2024 285
TABLE 307 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW 287
TABLE 308 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED 288
TABLE 309 ELANCO ANIMAL HEALTH INCORPORATED: DEALS, JANUARY 2021–AUGUST 2024 289
TABLE 310 ELANCO ANIMAL HEALTH INCORPORATED:
EXPANSIONS, JANUARY 2021–AUGUST 2024 289
TABLE 311 VETOQUINOL S.A.: COMPANY OVERVIEW 291
TABLE 312 VETOQUINOL S.A.: PRODUCTS OFFERED 293
TABLE 313 CEVA SANTÉ ANIMALE: COMPANY OVERVIEW 294
TABLE 314 CEVA SANTÉ ANIMALE: PRODUCTS OFFERED 294
TABLE 315 CEVA SANTÉ ANIMALE: DEALS, JANUARY 2021–AUGUST 2024 295
TABLE 316 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 296
TABLE 317 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED 297
TABLE 318 IDEXX LABORATORIES, INC.: OTHER DEVELOPMENTS,
JANUARY 2021–AUGUST 2024 298
TABLE 319 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 299
TABLE 320 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 301
TABLE 321 BIOCHEK SMART VETERINARY DIAGNOSTICS: COMPANY OVERVIEW 302
TABLE 322 BIOCHEK SMART VETERINARY DIAGNOSTICS: PRODUCTS OFFERED 302
TABLE 323 BIOCHEK SMART VETERINARY DIAGNOSTICS:
EXPANSIONS, JANUARY 2021–AUGUST 2024 303
TABLE 324 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW 304
TABLE 325 RING BIOTECHNOLOGY CO LTD.: PRODUCTS OFFERED 304
TABLE 326 RING BIOTECHNOLOGY CO LTD.: PRODUCT LAUNCHES,
JANUARY 2021–AUGUST 2024 305
TABLE 327 SEQUENT SCIENTIFIC LIMITED: COMPANY OVERVIEW 306
TABLE 328 SEQUENT SCIENTIFIC LIMITED: PRODUCTS OFFERED 307
TABLE 329 HIPRA: COMPANY OVERVIEW 308
TABLE 330 HIPRA: PRODUCTS OFFERED 308
TABLE 331 QIAGEN N.V.: COMPANY OVERVIEW 309
TABLE 332 QIAGEN N.V.: PRODUCTS OFFERED 310
TABLE 333 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW 311
TABLE 334 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED 311
TABLE 335 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS,
JANUARY 2021–AUGUST 2024 312
LIST OF FIGURES
FIGURE 1 MARKET SEGMENTATION 31
FIGURE 2 RESEARCH DESIGN 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS INC. 42
FIGURE 8 SUPPLY SIDE ANALYSIS: CATTLE & PORCINE REPRODUCTIVE
DISEASES MARKET (2023) 43
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES (2022–2029) 44
FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 44
FIGURE 11 TOP-DOWN APPROACH 45
FIGURE 12 DATA TRIANGULATION METHODOLOGY 46
FIGURE 13 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT,
2024 VS. 2029 (USD MILLION) 49
FIGURE 14 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS,
BY TYPE, 2024 VS. 2029 (USD MILLION) 50
FIGURE 15 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICAL PRODUCTS, BY TYPE, 2024 VS. 2029 (USD MILLION) 50
FIGURE 16 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS,
BY TYPE, 2024 VS. 2029 (USD MILLION) 51
FIGURE 17 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE,
2024 VS. 2029 (USD MILLION) 52
FIGURE 18 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE,
2024 VS. 2029 (USD MILLION) 52
FIGURE 19 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 53
FIGURE 20 GEOGRAPHIC SNAPSHOT OF CATTLE & PORCINE REPRODUCTIVE
DISEASES MARKET 54
FIGURE 21 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET 55
FIGURE 22 PHARMACEUTICALS SEGMENT ACCOUNTED FOR LARGEST MARKET
SHARE IN GERMANY IN 2023 56
FIGURE 23 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD 57
FIGURE 24 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 57
FIGURE 25 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
FIGURE 26 PRODUCTION OF MILK, BY REGION (MILLION METRIC TONS) 59
FIGURE 27 PRODUCTION OF MEAT, BY REGION (MILLION METRIC TONS) 60
FIGURE 28 PRODUCTION OF MEAT, BY ANIMAL TYPE (MILLION METRIC TONS) 60
FIGURE 29 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER (2019−2023) 62
FIGURE 30 NUMBER OF VETERINARIANS IN TOP FIVE EUROPEAN COUNTRIES (2023) 63
FIGURE 31 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET:
PORTER’S FIVE FORCES ANALYSIS 73
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 74
FIGURE 33 KEY BUYING CRITERIA FOR END USERS 74
FIGURE 34 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS 77
FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2013–DECEMBER 2023) 80
FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR CATTLE REPRODUCTIVE DISEASE TREATMENT PATENTS
(JANUARY 2013–DECEMBER 2023) 81
FIGURE 37 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR PORCINE REPRODUCTIVE DISEASE TREATMENT PATENTS
(JANUARY 2013–DECEMBER 2023) 82
FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR CATTLE & PORCINE REPRODUCTIVE DISEASE TREATMENT PATENTS (JANUARY 2013–DECEMBER 2023) 82
FIGURE 39 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ECOSYSTEM ANALYSIS 91
FIGURE 40 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: SUPPLY CHAIN ANALYSIS 96
FIGURE 41 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: VALUE CHAIN ANALYSIS 97
FIGURE 42 ADJACENT MARKETS FOR CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET 97
FIGURE 43 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 98
FIGURE 44 INVESTMENT & FUNDING ACTIVITIES IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, 2019–2023 98
FIGURE 45 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: GEOGRAPHIC SNAPSHOT 159
FIGURE 46 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET SNAPSHOT 172
FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET (2019−2023) 250
FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CATTLE & PORCINE
REPRODUCTIVE DISEASES MARKET (2023) 251
FIGURE 49 RANKING OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE
DISEASES MARKET, 2023 253
FIGURE 50 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS0, 2023 254
FIGURE 51 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY FOOTPRINT 255
FIGURE 52 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 262
FIGURE 53 YEAR-TO-YEAR (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 265
FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 265
FIGURE 55 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET:
BRAND/PRODUCT COMPARATIVE ANALYSIS 266
FIGURE 56 R&D EXPENDITURE OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, 2021−2023 266
FIGURE 57 ZOETIS INC.: COMPANY SNAPSHOT (2023) 271
FIGURE 58 MERCK & CO., INC.: COMPANY SNAPSHOT (2023) 276
FIGURE 59 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023) 280
FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2023) 284
FIGURE 61 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2023) 288
FIGURE 62 VETOQUINOL S.A.: COMPANY SNAPSHOT (2023) 292
FIGURE 63 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 297
FIGURE 64 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 300
FIGURE 65 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2023) 307
FIGURE 66 QIAGEN N.V.: COMPANY SNAPSHOT (2023) 310
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11